We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+5.43%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
-$110M
(-5.2%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-8.36%
Top 10 Holdings %
Top 10 Hldgs %
54.66%
Holding
88
New
23
Increased
17
Reduced
12
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$115M |
| 2 |
HCA Healthcare
HCA
|
+$108M |
| 3 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$85.2M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$79.8M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
+$56.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$68M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$67M |
| 3 |
Biogen
BIIB
|
+$63.6M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$56.2M |
| 5 |
Boston Scientific
BSX
|
+$42.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.27% |
| 2 | Financials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Edwards Lifesciences
EW
$50B
| $157M | 7.89% |
6,600,000
+5,100,000
| +340% | +$115M |
|
|
2
HCA Healthcare
HCA
$85.7B
| $122M | 6.17% |
+1,350,000
| New | +$108M |
|
3
CALL
Tenet Healthcare
THC
$21.8B
| $115M | 5.8% |
1,990,000
+1,770,000
| +805% | +$90.4M |
|
|
MNK
4
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $115M | 5.78% |
975,000
+175,000
| +22% | +$21.6M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $111M | 5.6% |
3,200,000
-800,000
| -20% | -$24.4M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $105M | 5.29% |
825,000
+125,000
| +18% | +$14.3M |
|
|
RAD
7
DELISTED
Rite Aid Corporation
RAD
| $100M | 5.05% |
600,000
+336,855
| +128% | +$56.5M |
|
8
Brookdale Senior Living
BKD
$3.49B
| $98.9M | 4.98% |
2,850,000
+900,000
| +46% | +$33.2M |
|
|
BCR
9
DELISTED
CR Bard Inc.
BCR
| $81.1M | 4.08% |
475,000
+275,000
| +138% | +$47M |
|
|
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
| $79.9M | 4.02% |
1,400,000
+650,000
| +87% | +$40.1M |
|
|
AKRX
11
DELISTED
Akorn Inc
AKRX
| $75.3M | 3.79% |
+1,725,000
| New | +$79.8M |
|
|
CVRS
12
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $70.1M | 3.53% |
+19,981,655
| New | +$85.2M |
|
13
Vertex Pharmaceuticals
VRTX
$122B
| $55.6M | 2.8% |
450,000
+175,000
| +64% | +$22.1M |
|
14
Cigna
CI
$76.1B
| $52.6M | 2.65% |
325,000
+291,841
| +880% | +$40.3M |
|
15
Danaher
DHR
$138B
| $51.4M | 2.59% |
892,699
+795,841
| +822% | +$45.6M |
|
16
Labcorp
LH
$25.9B
| $42.4M | 2.14% |
407,400
-378,300
| -48% | -$39.4M |
|
|
ALR
17
DELISTED
Alere Inc
ALR
| $38.2M | 1.93% |
725,000
-74,900
| -9% | -$3.77M |
|
|
ABCO
18
DELISTED
Advisory Board Co
ABCO
| $36.9M | 1.86% |
+675,000
| New | +$34.8M |
|
|
19
CALL
Edwards Lifesciences
EW
$50B
| $36.7M | 1.85% |
+1,545,600
| New | +$34.9M |
|
20
Acadia Pharmaceuticals
ACAD
$4.55B
| $34.6M | 1.74% |
825,000
+100,000
| +14% | +$3.87M |
|
|
21
CALL
Teva Pharmaceuticals
TEVA
$41.2B
| $27.8M | 1.4% |
470,000
-230,000
| -33% | -$14.2M |
|
|
RLYP
22
DELISTED
RELYPSA INC COM
RLYP
| $27.2M | 1.37% |
822,892
-52,108
| -6% | -$1.79M |
|
23
Integra LifeSciences
IART
$1.33B
| $26M | 1.31% |
944,827
+516,694
| +121% | +$13.8M |
|
|
IPXL
24
DELISTED
Impax Laboratories, Inc.
IPXL
| $25.3M | 1.27% |
+550,000
| New | +$26.1M |
|
25
PUT
Eli Lilly
LLY
$1.03T
| $25M | 1.26% |
+300,000
| New | +$22.9M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2015 Portfolio in Review
As of Q2 2015, HealthCor Management held 88 positions worth $1.99B, down 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
HealthCor Management withdrew a net $166M in Q2 2015, closing 35 positions and reducing 12 holdings. Its most notable exit was Viatris, an estimated $68M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 61% a quarter earlier, followed by Financials.
Against the trend, HealthCor Management opened a new position in HCA Healthcare worth $122M.
- HealthCor Management's largest Q2 2015 buy was HCA Healthcare: 1,350,000 shares worth $122M.
- HealthCor Management added most to Edwards Lifesciences in Q2 2015, an estimated $115M increase.
- HealthCor Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $67M.
- HealthCor Management fully exited Viatris in Q2 2015, selling an estimated $68M.
- HealthCor Management's ten largest holdings make up 55% of its $1.99B portfolio in Q2 2015.
- HealthCor Management opened 23 new positions and closed 35 in Q2 2015.
- HealthCor Management's portfolio value fell 5.2% quarter-over-quarter to $1.99B.
Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.